A public company CEO and Board Director with proven success leading emerging biopharmaceutical companies in the achievement of drug approvals, financings, and business development transactions. Extensive experience in formulating and implementing corporate strategies, establishing growth metrics, driving performance, and meeting growth objectives through organic expansion, acquisitions, and partnerships.
CORE COMPETENCIES
➢ Board member of private and public companies ➢ P&L management, strategic planning, and “hands-on” operations ➢ Extensive knowledge in clinical drug development (Phase I – Phase III) ➢ FDA regulatory pathways for clinical development and approval ➢ Raised $500M+ in corporate equity financing and M&A ➢ Business development and product licensing ➢ Managing large scale clinical studies involving 3,000+ participants ➢ Oncology, ophthalmology, women’s health, male and female hormone therapy, urology, growth disorders
